Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rebecca Straus Farber

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Annual Review of Medicine|September 23, 2015
Novel Agents for Relapsing Forms of Multiple SclerosisRebecca Straus Farber, Asaff Harel, Fred Lublin
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 28, 2016
Risk of venous thromboembolism in neuromyelitis optica patients hospitalized for acute relapseRebecca Straus Farber, Robert Gross, Elina Zakin, et al.
Journal of Neurovirology|July 11, 2018
Successful treatment of progressive multifocal leukoencephalopathy with recombinant interleukin-7 and maraviroc in a patient with idiopathic CD4 lymphocytopeniaAsaff Harel, Sam Horng, Tarah Gustafson, et al.
Journal of Magnetic Resonance Imaging : JMRI|September 30, 2009
Differentiating multiple sclerosis from other causes of demyelination using diffusion weighted imaging of the corpus callosumRebecca Straus Farber, Laetitia Devilliers, Aaron Miller, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 11, 2023
Vaccine-breakthrough SARS-CoV-2 infections in people with multiple sclerosis and related conditions: An observational study by the New York COVID-19 Neuro-Immunology Consortium (NYCNIC-2)Sylvia Klineova, Rebecca Straus Farber, Tracy DeAngelis, et al.
Brain Pathology (Zurich, Switzerland)|November 8, 2022
A 53-year-old woman with a rapidly progressive, non-enhancing left frontotemporal lesionMichael L Miller, Daniel W Griepp, Yu Sun, et al.
Clinical Rehabilitation|June 8, 2022
Feasibility trial of a telehealth support group intervention to reduce anxiety in multiple sclerosisAnne Kever, Ines M Aguerre, Wendy Vargas, et al.
Multiple Sclerosis and Related Disorders|July 24, 2024
A randomized cross-over trial of prebiotics and probiotics in multiple sclerosis: Trial feasibility, supplement tolerability and symptom abatementRebecca Straus Farber, Elizabeth Ls Walker, Fatoumata Diallo, et al.
Multiple Sclerosis and Related Disorders|December 22, 2023
Inflammatory vaginitis in four B-cell suppressed women with Multiple SclerosisLibby Levine, Jiyeon Son, Amy Yu, et al.
Plos One|April 25, 2017
Cerebellar volume as imaging outcome in progressive multiple sclerosisMatilde Inglese, Maria Petracca, Enricomaria Mormina, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Annual Review of Medicine|September 23, 2015
Novel Agents for Relapsing Forms of Multiple SclerosisRebecca Straus Farber, Asaff Harel, Fred Lublin
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 28, 2016
Risk of venous thromboembolism in neuromyelitis optica patients hospitalized for acute relapseRebecca Straus Farber, Robert Gross, Elina Zakin, et al.
Journal of Neurovirology|July 11, 2018
Successful treatment of progressive multifocal leukoencephalopathy with recombinant interleukin-7 and maraviroc in a patient with idiopathic CD4 lymphocytopeniaAsaff Harel, Sam Horng, Tarah Gustafson, et al.
Journal of Magnetic Resonance Imaging : JMRI|September 30, 2009
Differentiating multiple sclerosis from other causes of demyelination using diffusion weighted imaging of the corpus callosumRebecca Straus Farber, Laetitia Devilliers, Aaron Miller, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 11, 2023
Vaccine-breakthrough SARS-CoV-2 infections in people with multiple sclerosis and related conditions: An observational study by the New York COVID-19 Neuro-Immunology Consortium (NYCNIC-2)Sylvia Klineova, Rebecca Straus Farber, Tracy DeAngelis, et al.
Brain Pathology (Zurich, Switzerland)|November 8, 2022
A 53-year-old woman with a rapidly progressive, non-enhancing left frontotemporal lesionMichael L Miller, Daniel W Griepp, Yu Sun, et al.
Clinical Rehabilitation|June 8, 2022
Feasibility trial of a telehealth support group intervention to reduce anxiety in multiple sclerosisAnne Kever, Ines M Aguerre, Wendy Vargas, et al.
Multiple Sclerosis and Related Disorders|July 24, 2024
A randomized cross-over trial of prebiotics and probiotics in multiple sclerosis: Trial feasibility, supplement tolerability and symptom abatementRebecca Straus Farber, Elizabeth Ls Walker, Fatoumata Diallo, et al.
Multiple Sclerosis and Related Disorders|December 22, 2023
Inflammatory vaginitis in four B-cell suppressed women with Multiple SclerosisLibby Levine, Jiyeon Son, Amy Yu, et al.
Plos One|April 25, 2017
Cerebellar volume as imaging outcome in progressive multiple sclerosisMatilde Inglese, Maria Petracca, Enricomaria Mormina, et al.
Pageof 2